Arkray KDK gets Asian rights to Biosite cardiac test
Executive Summary
Arkray KDK (formerly Kyoto Dai-ichi Kagaku) licensed exclusive development and marketing rights to Biosite's (point-of-care tests) Triage Cardiac test in Japan, certain Asian countries, the Middle East, and Pacific Islands.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Chemistry, Immunoassay
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice